 |
|
One-Year Follow-Up of Serum Prolactin Level in Schizophrenia Patients Treated with Blonanserin: A Case Series
Sakae Takahashi, Masahiro Suzuki, Makoto Uchiyama
Psychiatry Investig. 2015;12(4):566-568. Published online 2015 Sep 30 DOI: https://doi.org/10.4306/pi.2015.12.4.566
|
|
Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments
Tae Maeshima, Ryosuke Iijima, Machiko Watanabe, Satoru Yui, Fumio Itagaki
Journal of Pharmaceutical Health Care and Sciences.2021;[Epub] CrossRef Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs
Akihiro Koreki, Hiroko Mori, Shoko Nozaki, Teruki Koizumi, Hisaomi Suzuki, Mitsumoto Onaya
Journal of Clinical Psychopharmacology.2021; 41(4): 474. CrossRef Comparison of long-term efficacy and safety of blonanserin treatment in individuals with first-episode and relapsed schizophrenia: a 3-year retrospective study
Lyang Huh, Bong Ju Lee
Psychiatry and Clinical Psychopharmacology.2019; 29(4): 399. CrossRef The impact of antipsychotics as a risk factor for thromboembolism
Ewa A. Ogłodek, Marek J. Just, Anna D. Grzesińska, Aleksander Araszkiewicz, Adam R. Szromek
Pharmacological Reports.2018; 70(3): 533. CrossRef
|